aTYR PHARMA INC (ATYR) Form 8-K — Jun 8, 2026

$ATYRForm 8-KItems 3.01Filed Jun 8, 2026, 8:00 AM ET0001339970-26-000039Original filing

aTyr Pharma (ATYR) reported that it failed to regain compliance with Nasdaq’s minimum $1.00 bid price requirement by the initial June 2, 2026 deadline. The company received a letter from Nasdaq granting an additional 180-day compliance period, extending the deadline to November 30, 2026. The filing explicitly states that the company intends to cure the deficiency by effecting a reverse stock split, if necessary. Failure to regain compliance by the November deadline will result in a delisting notice, though the company may appeal that determination.

Key figures

Minimum bid price: $1.00
Final compliance date: November 30, 2026
Initial compliance date: June 2, 2026

Price after filing

1 day: +3.1%7 days: +0.3%30 days: +37.1%

Close on the filing date to close N calendar days later (from $0.44). Historical, not a forecast.

AI analysis

Red flags4 · Pro

The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.

Upgrade to Pro · $49/mo billed annually

AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.